Clinical Trial Update: Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease [Phase 3]

View source ↗

Summary

An ongoing Phase 3 open-label extension trial evaluating MHB018A in people with Thyroid Eye Disease, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• MHB018A

Snippet

Sponsor: Minghui Pharmaceutical (Hangzhou) Ltd | Conditions: Thyroid Eye Disease (TED) | Phase 3 | Status: RECRUITING